pH Sensitive Erythrocyte-Derived Membrane for Acute Systemic Retention and Increased Infectivity of Coated Oncolytic Vaccinia Virus
Authors:
- Kaelan T. SamoranosKaelan T. Samoranos
- Alexandra L. KrisiewiczAlexandra L. Krisiewicz
- Bianca C. KarpineczBianca C. Karpinecz
- Philip A. GloverPhilip A. Glover
- Trevor V. GaleTrevor V. Gale
- Carla ChehadehCarla Chehadeh
- Sheikh AshshanSheikh Ashshan
- Richard KoyaRichard Koya
- Eddie Y. ChungEddie Y. Chung
- Han L. LimHan L. Lim
Open Access
- 28 August 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1810
Abstract
Oncolytic viruses have emerged as a promising modality in cancer treatment given their high synergy with highly efficient immune checkpoint inhibitors. However, their potency is limited by their rapid in vivo clearance. To overcome this, we coated oncolytic vaccinia viruses (oVV) with erythrocyte-derived membranes (EDMs), hypothesizing that they would not only remain in systemic circulation for longer as erythrocytes would when administered intravenously, but also respond to environmental pH cues due to their membrane surface sialic acid residues. For this, we developed a model based on DLVO theory to show that the acidic moieties on the surface of EDM confers it the ability to respond to pH-based stimuli. We corroborate our modeling results through in vitro cell culture models and show that EDM-coated oVV infects cancer cells faster under acidic conditions akin to the tumor microenvironment. When EDM-coated oVVs were intravenously injected into wild-type mice, they exhibited prolonged circulation at higher concentrations when compared to the unprocessed oVV. Furthermore, when EDM-coated oVV was directly injected into xenografted tumors, we observed that they were suppressed earlier than the tumors that received regular oVV, suggesting that the EDM coating does not hinder oVV infectivity. Overall, we found that EDM was able to serve as a multi-functional encapsulant that allowed the payload to remain in circulation at higher concentrations when administered intravenously while simultaneously exhibiting pH-responsive properties.Keywords
Funding Information
- Coastar Therapeutics Inc.
This publication has 41 references indexed in Scilit:
- CD47 functions as a removal marker on aged erythrocytesISBT Science Series, 2013
- Inhibitors of C5 complement enhance vaccinia virus oncolysisCancer Gene Therapy, 2013
- PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized MiceJournal of Virology, 2013
- CD47 in Erythrocyte Ageing and Clearance – the Dutch Point of ViewTransfusion Medicine and Hemotherapy, 2012
- Vaccinia Virus A25 and A26 Proteins Are Fusion Suppressors for Mature Virions and Determine Strain-Specific Virus Entry Pathways into HeLa, CHO-K1, and L CellsJournal of Virology, 2010
- Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivoGene Therapy, 2008
- Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial GliomaStem Cells, 2008
- Calculation of interparticle spacing in colloidal systemsJournal of Colloid and Interface Science, 2006
- Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitroGene Therapy, 1998
- Influence of Lipid Composition and Ionic Strength on the Physical Stability of LiposomesJournal of Pharmaceutical Sciences, 1984